Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Emollient Lotion Manufacturing and Formulation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the manufacture of a non-sterile emollient lotion packaged in 240 mL bottles equipped with dispenser caps, with strict adherence to specified pH and viscosity standards to ensure product consistency and performance. The work is classified under NAICS code 325620, indicating it falls within the pharmaceutical and medicinal chemical manufacturing sector, and is structured as a subcontract under the Department of Defense’s Medical Supply Chain PHSA. Performance is required at Fort Bliss, Texas, with a zip code of 79918-2527, and all production must comply with the technical specifications outlined in the solicitation. The solicitation was posted on July 28, 2026, with a firm response deadline of August 3, 2026, leaving a limited window for qualified manufacturers to submit proposals. While no set-aside classification is specified, the contract is part of a broader defense supply chain effort and demands precision in formulation and packaging to meet operational medical needs. The place of performance is fixed, and all deliveries must be coordinated to fulfill the requirements of the U.S. military medical supply system, with no indication of international delivery or alternative distribution points.

General Info

Manufacture of non-sterile emollient lotion in 240 mL bottles for DoD at Fort Bliss, Texas, meeting strict pH and viscosity specs.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325620 - Toilet Preparation ManufacturingView NAICS

Place of Performance

FORT BLISS, TX, 79918-2527, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufacture of non-sterile emollient lotion in 240 mL bottles with dispenser caps, meeting specified pH and viscosity requirements.

Similar Contracts

Same NAICS industry code

NAICS: 325620
New
DIBBS
Medical Supply Fulfillment – Surgical Rubber BandagesThe contract pertains to the supply and delivery of surgical rubber bandages identified by NSN 6510012878134, with packaging requirements specifying 20 units per package, intended for military medical operations at Fort Bliss, Texas. These bandages are designated for critical medical use within the Department of Defense healthcare system and must meet stringent quality and compliance standards for wartime and field medical scenarios. The solicitation is structured as a subcontract under NAICS code 325620, which classifies the industry as Rubber and Plastics Product Manufacturing, indicating the need for specialized production capabilities aligned with medical device specifications. The opportunity was posted on July 28, 2026, with a firm response deadline of August 3, 2026, allowing potential vendors a brief window to prepare and submit their proposals. The place of performance is clearly identified as Fort Bliss with a ZIP code of 79918-2527, emphasizing localized logistics and timely delivery requirements to support military medical readiness. Although no point of contact or set-aside provisions are specified, the contract is issued under the Medical Supply Chain MD SURG FSF, a unit within the broader Department of Defense supply infrastructure, ensuring alignment with defense medical procurement protocols. All submissions must adhere to the official procurement platform accessible via the provided DIBBS link to be considered valid.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325620
New
DIBBS
Supply of Blood Collection and Dispensing KitsThe contract calls for the manufacture and delivery of FDA-compliant blood collection and dispensing kits containing sterile needles, tubing, and blood storage bags, all of which must adhere to stringent medical-grade standards for sterility, labeling, and shelf-life integrity. The products must meet all regulatory requirements necessary for safe use in clinical and military medical environments, ensuring reliability and compliance with U.S. health and safety protocols. The kits are intended for distribution and use at Fort Bragg, North Carolina, under the oversight of the Department of Defense's Medical Supply Chain division, indicating a critical readiness and operational medical support function. This is a subcontract opportunity with a NAICS code of 325620, classifying it under Medical Equipment and Supplies Manufacturing, and it has a response deadline of August 3, 2026. The solicitation was posted on July 28, 2026, and is part of the Defense Logistics Agency’s procurement system, signaling the need for qualified suppliers capable of meeting rapid deployment and quality assurance demands within a tight timeframe. The contract requires complete adherence to federal medical device regulations, with no set-aside provisions specified, opening eligibility to all qualified vendors. Proposals must demonstrate technical capability, compliance documentation, and capacity to produce and deliver the kits accurately to the specified location in support of DoD medical operations.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
Pharmaceutical Preparation Manufacturing

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details